Economy · Full coverage
Credit Card Firm Cal Deal Collapses, Potentially Benefiting Discount Bank
How 2 Israeli newsrooms covered this story — translated into English and compared side by side.
Unrated 2
By אדיר בן עמי
First reported by Globes · 3 hours ago
What happened
A deal for the sale of Israeli credit card company Cal has faltered due to the Competition Authority's demand that a buyer divest its stake in rival pharmacy chain Super-Pharm. Discount Bank, which is mandated to sell its stake, may now consider retaining Cal or seeking alternative buyers or an IPO.
- 01Cal credit card company sale deal collapses over regulatory demands.
- 02Authority requires buyer Union to sell Super-Pharm stake due to data concerns.
- 03Discount Bank may keep Cal or seek new buyers/IPO.
- 04Cal shows continued growth despite losing El Al's Fly Card.
- 05Deal's failure could benefit Discount Bank financially in the long run.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 2 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
Related stories
Credit Card Firm Calcal Deal Collapses Over Super-Pharm Holdings3 hours agoCredit Card Firm Calá Deal Collapses Amid Antitrust ConcernsSep 14, 2026Discount Bank Seeks to Cancel Cal Credit Card Sale Amid Regulatory HurdlesSep 8, 2026Discount Bank Warns Credit Card Firm Sale May CollapseSep 9, 2026Discount Bank and Union Group Push for Unconditional Approval of Cal Sale by Competition AuthorityJul 6, 2026Cal Credit Company Appoints New Senior Executives Amid Pending Sale to Union GroupAug 11, 2026